|Security||AMAR / Amarillo Biosciences, Inc. (02301P205)|
|President, CEO & Chairman||CHEN STEPHEN T|
|Institutional Shares||1,526 - 0.01%|
|Common Stock Shares Outstanding And Reserved||28,731,754 shares (as of 2017-09-30)|
Institutional Stock Ownership and Shareholders
Amarillo Biosciences, Inc. (OTC:AMAR) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,526 shares. Largest shareholders include Alpha Omega Wealth Management LLC.
Amarillo Biosciences, Inc. (OTC:AMAR) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Stop missing out on important events!
|File Date||Form||Investor||Opt||Prev Shares||Current Shares||Change
|Prev Value (x$1000)||Current Value (x$1000)||Change|
|Alpha Omega Wealth Management LLC||1,526||1,526||0.00||0||0|